Myc-tag Antibody

What is a Myc-tag and why is it commonly used in protein research?

The Myc-tag is a short synthetic polypeptide sequence derived from the human c-Myc protein, specifically from amino acid residues 410-419. It serves as a widely used epitope tag for detecting recombinant proteins in various expression systems including bacteria, yeast, insect, and mammalian cells . The tag provides a reliable method for detection and purification of tagged target proteins without requiring protein-specific antibodies, which is particularly valuable when studying novel proteins for which specific antibodies are unavailable or costly to produce .

What is the amino acid sequence of the Myc-tag?

The standard Myc-tag consists of 10 amino acids with the sequence EQKLISEEDL . In some applications, researchers use a double Myc-tag (2xMyc: EQKLISEEDLEQKLISEEDL), which repeats the sequence to enhance binding affinity and detection sensitivity .

What types of Myc-tag antibodies are available for research applications?

Multiple formats of Myc-tag antibodies are available for different research applications:

These antibodies vary in source organism, class (IgG, IgG1), conjugation (unconjugated, HRP, FITC, biotin, agarose/magnetic beads), and specific binding properties .

Should I choose 1xMyc-tag or 2xMyc-tag for my protein of interest?

The choice depends on your experimental goals:

1xMyc-tagged protein:

• Suitable for all types of immunoprecipitation and co-immunoprecipitation

• Ideal when effective and/or gentle elution of native protein is required

• Better for applications where minimal tag size is preferred

2xMyc-tagged protein:

• Provides extraordinary binding affinity (KD of 0.5 nanoMolar with anti-Myc nanobody)

• Ideal for low-abundance proteins

• Favors downstream on-bead processing techniques

Consider the elution effectiveness when choosing between these options:

(Key: o = minimal, + = moderate, ++ = good, +++ = excellent)

Where should I place the Myc-tag on my protein of interest?

The Myc-tag can be placed at the N-terminus, C-terminus, or internally within a protein of interest. Consider these factors:

• Protein structure and function: Avoid placing tags near functional domains that might interfere with activity

• Accessibility: Ensure the tag remains accessible to antibodies for detection

• Protein localization: Consider how the tag might affect targeting signals

• Protein stability: Some proteins may be destabilized by terminal tags

Notable findings: Recent molecular dynamics simulations and in vivo studies showed that a c-Myc tag at the N-terminus of an FMC63-based anti-CD19 scFv did not affect structural equilibrium and granted stability, but caused steric impediment that disturbed interaction with CD19 protein, resulting in worse antitumor activity in CAR-T cells . Similar effects were observed with C-terminal tags, suggesting careful consideration of tag positioning is essential for functional studies .

Avoid fusing the Myc-tag to secretory signals . The Myc-Trap recognizes the tag sequence regardless of its position within the fusion protein .

What are the recommended dilutions for different applications of Myc-tag antibodies?

Always refer to the specific antibody datasheet for recommended dilutions and optimize for your experimental conditions .

How might the Myc-tag affect protein structure and function?

While generally considered to have minimal impact, the Myc-tag can potentially affect proteins in several ways:

• Steric hindrance: May interfere with binding sites or interaction surfaces

• Altered folding: Could affect protein folding, particularly if placed near critical structural elements

• Changed solubility: Tags can sometimes modify protein solubility

• Stability effects: Some proteins may be stabilized or destabilized by tags

• Localization impact: Tags might mask or interfere with localization signals

A molecular dynamics study demonstrated that while a c-Myc tag in the N-terminus position didn't disrupt an scFv's structural equilibrium and granted stability, it caused steric impediment that disrupted interaction with the target protein CD19 . CAR-T cell experiments confirmed cells with the c-Myc tag showed worse antitumor activity .

To minimize potential effects:

• Test multiple tag positions when possible

• Include untagged controls in experiments

• Validate that tagged proteins retain expected function

• Consider adding cleavage sites to remove tags if necessary

Why might my Myc-tagged protein not be detected by the Myc-tag antibody?

Several factors could contribute to poor detection:

• Epitope accessibility: The tag may be occluded by protein structure

• Context-dependent recognition: The widely used 9E10 clone displays highly variable epitope recognition depending on sequences adjacent to the tag

• Expression levels: Low expression may be below detection threshold

• Protein degradation: The tag or entire protein may be degraded

• Inefficient transfer: Large proteins may transfer poorly in Western blotting

• Antibody dilution: Too dilute antibody may result in weak signal

• Fixation conditions: Some fixation methods may mask the epitope

Troubleshooting approaches:

• Try different Myc-tag antibodies - some newer antibodies appear less sensitive to sequence context

• Adjust antibody concentration

• Use enhanced detection systems

• Try different tag positions

• Consider using a 2xMyc-tag for enhanced detection

• Optimize experimental conditions (lysis buffer, fixation method)

What controls should I include when using Myc-tag antibodies?

Proper controls are essential for interpreting results:

For Immunoprecipitation:

• Myc-Trap for IP of Myc-fusions and a non-relevant trap as negative control

• Non-transfected or mock-transfected cells

• Input sample (pre-IP lysate) to assess IP efficiency

• IgG control to identify non-specific binding

For Western Blotting:

• Lysate from cells expressing an unrelated Myc-tagged protein (positive control)

• Lysate from non-transfected cells (negative control)

• Molecular weight markers to confirm expected size

For Immunofluorescence:

• Cells expressing Myc-tagged control protein

• Non-transfected cells

• Secondary antibody only control

• Competitive blocking with Myc peptide

How do I address variability in Myc-tag antibody recognition based on sequence context?

Research has shown that some Myc-tag antibodies, particularly the 9E10 clone, display highly variable epitope recognition depending on sequences adjacent to the tag . To address this issue:

• Test newer Myc-tag antibodies that appear less sensitive to sequence context

• Evaluate multiple different anti-Myc antibodies with your specific construct

• Use a 2xMyc-tag to potentially enhance recognition

• Insert a short linker sequence between your protein and the Myc-tag

• Try different positions for the tag

• Validate detection with an antibody against your protein of interest if possible

• For critical applications, sequence the region around the tag to ensure it matches expected sequence

• Consider nanobody-based detection systems, which may have different binding characteristics

What are the best practices for immunoprecipitation of Myc-tagged proteins?

For optimal immunoprecipitation:

Cell Lysis:

• Use mild conditions to maintain protein-protein interactions

• Typical lysis buffers: 150 mM NaCl, 50 mM Tris pH 7.5, 1% non-denaturing detergent

• Include protease and phosphatase inhibitors

• Clarify lysates by centrifugation (14,000 × g, 10 min, 4°C)

Binding:

• Pre-clear lysate with protein A/G beads to reduce non-specific binding

• For conventional antibodies: Add 1-5 μg antibody per 1 mg lysate

• For Myc-Trap: Add beads directly to lysate

• For low-abundance proteins: Consider longer incubation times

Washing:

• Perform 3-5 washes with buffer containing reduced detergent

• More stringent washes can reduce background but may disrupt weak interactions

Elution strategies:

• For native elution of 1xMyc-tagged proteins:

  • Competitive elution with Myc peptide (40 μM) or 2xMyc peptide (40 μM)

• For denaturing elution:

  • 8M urea (effective for 1xMyc-tagged proteins)

  • SDS sample buffer with heating (95°C, 10 min)

How do nanobody-based Myc-Traps compare to conventional Myc-tag antibodies?

Nanobody-based Myc-Traps offer several advantages over conventional antibodies:

Structure and Size:

• Conventional antibodies comprise two heavy and light chains that can contaminate pulled-down proteins

• The anti-Myc nanobody is a single domain antibody, resulting in cleaner purification

• Particularly advantageous when detecting proteins similar in size to antibody chains

Binding Properties:

• Anti-Myc nanobody has a very low dissociation constant (KD of 0.5 nanoMolar for 2xMyc-tagged proteins)

• Results in strong binding and high affinity

• Beneficial for low-abundance proteins

Reproducibility:

• The Myc-Trap nanobody is a small, soluble, stable polypeptide recombinantly expressed in bacteria

• Minimal lot-to-lot variations compared to conventional antibodies

• Production is robust and reproducible

Limitations:

• Anti-Myc nanobody is not suitable for detection of Myc-fusion proteins in Western Blots

• For Western Blot detection, conventional anti-Myc antibodies are recommended

• Strong binding of 2xMyc-tagged proteins makes native elution challenging

Can Myc-tag antibodies be used for chromatin immunoprecipitation (ChIP)?

Yes, Myc-tag antibodies can be used for ChIP experiments to study protein-DNA interactions for proteins lacking specific ChIP-grade antibodies. Key considerations:

• Fixation: Standard formaldehyde fixation protocols (1% formaldehyde, 10 minutes) are generally compatible

• Sonication: Typical protocols generating 200-500 bp fragments work well

• Antibody selection: Use ChIP-validated Myc-tag antibodies; the monoclonal anti-Myc tag antibody 5A5 has been validated for ChIP applications

• Controls: Include non-transfected cells as negative control and input samples as reference

• Tag position: Ensure the tag doesn't interfere with DNA binding

• Expression level: Overexpression may lead to non-specific binding; consider endogenous promoters

• Validation: Confirm findings with alternative approaches when possible

What are the considerations for using Myc-tag in in vivo experiments?

When designing in vivo experiments with Myc-tagged proteins, consider:

Immunogenicity:

• The Myc-tag may be immunogenic in animal models

• Can lead to immune responses against the tagged protein

• Consider species-specific tags for long-term studies

Functional impact:

• Tags can significantly affect protein function in vivo

• A c-Myc tag on an anti-CD19 scFv granted stability but reduced antitumor activity in CAR-T cells

• Both N-terminal and C-terminal positions showed similar negative effects

Detection in tissues:

• For immunohistochemistry, optimize fixation protocols

• Paraformaldehyde fixation (4%) works well for many applications

• Antigen retrieval may be necessary for formalin-fixed tissues

Alternative approaches:

• Consider fluorescent protein fusions for in vivo tracking

• For therapeutic applications, evaluate tag-free designs or removable tags

• Fluorescent reporters or independent membrane reporters might prove more suitable to avoid undesirable effects